Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence

Indian Journal of Community Medicine

Volumn 37, Issue 2, 2012, Pages 89-94

  Reid, Savanna ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

cost benefit; hepatitis B virus; hepatitis C virus; HIV; injections

Indexed keywords

EID: 84861312474     PISSN: 09700218     EISSN: 19983581     Source Type: Journal    
DOI: 10.4103/0970-0218.96093     Document Type: Article

References (50)

1. Lakshman M, Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: An ethnographic study. Soc Sci Med 2000;51:11-28.
2. Perz JF, Thompson ND, Schaefer MK, Patel PR. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 2010;14:137-51; x.
3. Okwen MP, Ngem BY, Alomba FA, Capo MV, Reid SR, Ewang EC. Uncovering high rates of unsafe injection equipment reuse inrural Cameroon: validation of a survey instrument that probes for specific misconceptions. Harm Reduct J 2011;8:4.
4. Rahman S. Recycling of medical waste causes deadly virus outbreak. Available from: http://www.thenational.ae/article/20090312/FOREIGN/97643596/ 1103/NEWS. [Last accessed on 2010 Jan 1].
5. Kotwal A, Priya R, Thakur R, Gupta V, Kotwal J, Seth T. Injection practices in a metropolis of North India: perceptions, determinants and issues of safety. Indian J Med Sci 2004;58:334-44.
6. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004;15:7-16.
7. Arora N. Assessment of injection practices in India. INCLEN Trust. Available from: http://www.ipen.org.in/images/stories/exec.%20summary.pdf. [Last accessed on 2010 Jan 3].
8. Department of AIDS Control, Ministry of Health and Family Welfare. Annual Report 2009-2010.
9. UNAIDS. 2008 Report on the global AIDS epidemic. Available from: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/. [Last accessed on 2010 Jul 29].
10. Kumar Hn H, Jayaram S, Rao MR, Kumar S SG, Kotian M. Recent trends in HIV incidence in coastal South India: Implications for prioritizing HIV control strategies. Open Med 2009;3:e26-30.
11. Marx MA, Murugavel KG, Tarwater PM, SriKrishnan AK, Thomas DL, Solomon S, et al. Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis 2003;37:514-20.
12. Mehendale SM, Rodrigues JJ, Brookmeyer RS, Gangakhedkar RR, Divekar AD, Gokhale MR, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172:1486-91.
13. Mehendale SM, Shepherd ME, Divekar AD, Gangakhedkar RR, Kamble SS, Menon PA, et al. Evidence for high prevalence and rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian J Med Res 1996;104:327-35.
14. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003;187:1513-21.
15. Kurien T, Thyagarajan SP, Jeyaseelan L, Peedicayil A, Rajendran P, Sivaram S, et al. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res 2005;121:670-5.
16. Risbud A, Mehendale S, Basu S, Kulkarni S, Walimbe A, Arankalle V, et al. Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India. Sex Transm Infect 2002;78:169-73.
17. Singh J, Bhatia R, Patnaik SK, Khare S, Bora D, Jain DC, et al. Community studies on hepatitis B in Rajahmundry town of Andhra Pradesh, India, 1997-1998: unnecessary therapeutic injections are a major risk factor. Epidemiol Infect 2000;125:367-75.
18. Singh S, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infection sin Indian kala-azar patients receiving injectable anti-leishmanial drugs: A community-based study. Int J Infect Dis 2000;4:203-8.
19. Singh S, Dwivedi S, Sood R, Wali JP. Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kalaazar patients in Delhi. Scand J Infect Dis 2000;32:3-6.
20. Marx MA, Murugavel KG, Sivaram S, Balakrishnan P, Steinhoff M, Anand S, et al. The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India. Am J Trop Med Hyg 2003;68:258-62.
21. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: A community-based study in West Bengal, India. Hepatol 2003;37:802-9.
22. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: A review. Bull World Health Organ 1999;77:789-800.
23. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in Northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:500-7.
24. Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999;28:782-6.
25. Janjua NZ, Hamza HB, Islam M, Tirmizi SF, Siddiqui A, Jafri W, et al. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infectino in Karachi, Pakistan. J Viral Hepat 2010;17:317-26.
26. Quigley MA, Morgan D, Malamba SS, Mayanja B, Okongo MJ, Carpenter LM, et al. Case-control study of risk factors for incidence HIV infection in rural Uganda. J Acquir Immune Defic Syndr 2000;23:418-25.
27. Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP. Injections in health care settings: A risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Epidemiol Infect 2003;130:293-300.
28. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000;78:956-63.
29. Williams ML, McCurdy SA, Bowen AM, Kilonzo GP, Atkinson JS, Ross MW, et al. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev 2009;21:474-83.
30. Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: A case-control study. AIDS Care 2009;21:7-16.
31. Mahanta J, Borkakoty B, Das HK, Chelleng PK. The risk of HIV and HCV infections among injectino drug users in northeast India. AIDS Care 2009;21:1420-4.
32. Gibellini D, Borderi M, Bon I, Biagetti C, De Crignis E, Re MC. HIV-1 infection of a nurse from a newborn with an unknown HIV infection: A case report. J Clin Virol 2009;46:374-7.
33. Sugauchi F, Mizokami M, Orito E, Ohno T, Hayashi K, Kato T, et al. Molecular evolutionary analysis of the complete nucleotide sequence of hepatitis B virus (HBV) in a case fo HBV infection acquired through a needlestick accident. Clin Infect Dis 2000;31:1195-201.
34. Libois A, Fumero E, Castro P, Nomdedeu M, Cruceta A, Gatell JM, et al. Transmission of hepatitis C virus by discarded-needle injury. Clin Infect Dis 2005;41:129-30.
35. Bobkov A, Garaev MM, Rzhaninova A, Kaleebu P, Pitman R, Weber JN, et al. Molecular epidemiology of HIV-1 in the former Soviet Union: Analysis of env V3 sequences and their correlation with epidemiologic data. AIDS 1994;8:619-24.
36. Pourkarim MR, Verbeeck J, Rahman M, Amini-Bavil-Olyaee S, Forier AM, Lemey P, et al. Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium. J Clin Virol 2009;46:61-8.
37. Centers for Disease Control and Prevention (CDC). Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic - Nevada, 2007. MMWR Morb Mortal Wky Rep 2008;57:513-7.
38. Rajasekaran M, Sivagnanam G, Thirumalaikolundusubramainan P, Namasivayam K, Ravindranath C. Injection practices in southern part of India. Public Health 2003;117:208-13.
39. Bhave S, Kamath SS, Shah R. Injection safety and Indian Academy of Pediatrics. J Indian Med Assoc 2005;103:228-30, 232.
40. Dziekan G, Chisholm D, Johns B, Rovira J, Hutin YJ. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings. Bull World Health Organ 2003;81:277-85.
41. Emmanuel F. Outbreak Investigation, Mohalla JogiPura, Jalal Pur Jattan. HIV/AIDS Surveillance Project, 2010.
42. Gisselquist D. How much do blood exposures contribute to HIV prevalence in female sex workers in sub-Saharan Africa, Thailand and India? Int J STD AIDS 2007;18:581-8.
43. Schmid GP, Buvé A, Mugyenyi P, Garnett GP, Hayes RJ, Williams BG, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004;363:482-8.
44. Reid S, Juma OA. Minimum infective dose of HIV for parenteral dosimetry. Int J STD AIDS 2009;20:828-33.
45. Rothman RE, Majmudar MD, Kelen GD, Madico G, Gaydos CA, Walker T, et al. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J Infect Dis 2002;186:1677-81.
46. Park KH, Kim SH, Song EH, Jang EY, Lee EJ, Chong YP, et al. Development of bacteraemia of fungaemia after removal of colonized central venous catheters in patients with negative concomitant blood cultures. Clin Microbiol Infect 2009;16:742-6.
47. Hoelscher M, Riedner G, Hemed Y, Wagner HU, Korte R, von Sonnenburg F. Estimating the number of HIV transmission through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994;8:1609-15.
48. Mortimer PP. Away with multi-use vials! AIDS 1999;13:1779-81.
49. Plott RT, Wagner RF Jr, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990;126:1441-4.
50. Correa M, Gisselquist D. Routes of HIV transmission in India: Assessing the reliability of information on AIDS case surveillance. Int J STD AIDS 2006;17:731-5.